We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+10.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$63.8B
AUM Growth
+$3.93B
Cap. Flow
-$1.01B
Cap. Flow %
-1.58%
Top 10 Hldgs %
22.75%
Holding
3,125
New
60
Increased
388
Reduced
2,521
Closed
139

Sector Composition

Rank Sector Weight
1 Technology 24.2%
2 Healthcare 13.87%
3 Financials 12.55%
4 Consumer Discretionary 11.87%
5 Communication Services 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOGO icon
2176
Gogo Inc
GOGO
$468M
$636K ﹤0.01%
68,796
-13,513
-16% -$73.8K
GSBC icon
2177
Great Southern Bancorp
GSBC
$872M
$635K ﹤0.01%
17,521
-2,351
-12% -$88.7K
LGTY
2178
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$635K ﹤0.01%
45,202
-5,160
-10% -$80.5K
GERN icon
2179
Geron
GERN
$962M
$634K ﹤0.01%
364,630
+51,324
+16% +$94.9K
SP
2180
DELISTED
SP Plus Corporation
SP
$634K ﹤0.01%
35,308
-4,920
-12% -$90.4K
HBNC icon
2181
Horizon Bancorp
HBNC
$1.04B
$630K ﹤0.01%
62,426
-9,135
-13% -$94.8K
LQDT icon
2182
Liquidity Services
LQDT
$1.28B
$628K ﹤0.01%
84,218
-4,714
-5% -$31K
EVER icon
2183
EverQuote
EVER
$892M
$627K ﹤0.01%
16,221
-3,024
-16% -$136K
GRBK icon
2184
Green Brick Partners
GRBK
$3.02B
$625K ﹤0.01%
38,798
-5,507
-12% -$81.2K
BV icon
2185
BrightView Holdings
BV
$1.06B
$623K ﹤0.01%
54,646
-341
-0.6% -$4.09K
VKTX icon
2186
Viking Therapeutics
VKTX
$4.03B
$621K ﹤0.01%
106,683
-14,089
-12% -$97K
PDLI
2187
DELISTED
PDL BioPharma, Inc.
PDLI
$621K ﹤0.01%
197,055
-28,273
-13% -$90.3K
TCRR
2188
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$619K ﹤0.01%
30,451
+8,191
+37% +$144K
ANAT
2189
DELISTED
American National Group, Inc. Common Stock
ANAT
$619K ﹤0.01%
9,164
+439
+5% +$31.9K
CTBI icon
2190
Community Trust Bancorp
CTBI
$1.41B
$618K ﹤0.01%
21,867
-5,277
-19% -$166K
BABA icon
2191
Alibaba
BABA
$314B
$616K ﹤0.01%
2,097
-8,717
-81% -$2.3M
PRTA icon
2192
Prothena Corp
PRTA
$442M
$612K ﹤0.01%
61,305
-7,046
-10% -$84.8K
CONN
2193
DELISTED
Conn's Inc.
CONN
$612K ﹤0.01%
57,890
-4,305
-7% -$46.5K
TSM icon
2194
TSMC
TSM
$2.2T
$609K ﹤0.01%
7,511
-33,434
-82% -$2.54M
SGRY icon
2195
Surgery Partners
SGRY
$1.97B
$608K ﹤0.01%
27,748
-3,785
-12% -$67.3K
LGF.A
2196
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$607K ﹤0.01%
64,065
+5,928
+10% +$51.2K
RLMD icon
2197
Relmada Therapeutics
RLMD
$515M
$602K ﹤0.01%
15,998
-1,845
-10% -$71.3K
ALEC icon
2198
Alector
ALEC
$185M
$601K ﹤0.01%
57,012
-9,445
-14% -$153K
MRC
2199
DELISTED
MRC Global
MRC
$601K ﹤0.01%
140,365
-16,795
-11% -$96.5K
BTAI icon
2200
BioXcel Therapeutics
BTAI
$28.9M
$599K ﹤0.01%
864
-102
-11% -$76.6K

Similar funds

RhumbLine Advisers's Q3 2020 Portfolio in Review

As of Q3 2020, RhumbLine Advisers held 3,125 positions worth $63.8B, up 6.6% from $59.9B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

RhumbLine Advisers's Q3 2020 filing shows 60 new, 388 increased, 2,521 reduced and 139 closed positions. Its largest new stake was PROG Holdings: 245,531 shares worth $11.8M. The largest sale was Apple, an estimated $59.2M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

  • RhumbLine Advisers's largest Q3 2020 buy was PROG Holdings: 245,531 shares worth $11.8M.
  • RhumbLine Advisers added most to Match Group in Q3 2020, an estimated $20M increase.
  • RhumbLine Advisers's biggest Q3 2020 reduction was Apple, cutting an estimated $59.2M.
  • RhumbLine Advisers fully exited Caesars Entertainment Corporation in Q3 2020, selling an estimated $19.1M.
  • RhumbLine Advisers's ten largest holdings make up 23% of its $63.8B portfolio in Q3 2020.
  • RhumbLine Advisers opened 60 new positions and closed 139 in Q3 2020.
  • RhumbLine Advisers's portfolio value rose 6.6% quarter-over-quarter to $63.8B.

Based on RhumbLine Advisers's 13F filing for Q3 2020, filed 12 Nov 2020.